1. Home
  2. BDRX vs UGRO Comparison

BDRX vs UGRO Comparison

Compare BDRX & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$0.69

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$6.31

Market Cap

1.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDRX
UGRO
Founded
2000
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.9M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
BDRX
UGRO
Price
$0.69
$6.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.0K
56.3K
Earning Date
09-12-2025
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$40,008,850.00
Revenue This Year
N/A
$98.41
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.11
52 Week High
$11.88
$4.50

Technical Indicators

Market Signals
Indicator
BDRX
UGRO
Relative Strength Index (RSI) 25.48 80.95
Support Level N/A $0.28
Resistance Level $1.29 N/A
Average True Range (ATR) 0.07 0.60
MACD 0.02 0.16
Stochastic Oscillator 10.25 86.02

Price Performance

Historical Comparison
BDRX
UGRO

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: